The Food and Drug Law Institute (FDLI) is hosting a two-day virtual conference this week to discuss “legal and practical issues in the evolving world of cannabis regulations”, as reported today by 

Yesterday morning, Joseph Franklin, policy director for Amy Abernathy, spoke about the FDA’s approach CBD.  Abernathy, a principal deputy commissioner at FDA, has led the agencies work in crafting CBD regulations thus far.   

One attendee asked about the agencies’ timing in releasing regulations for CBD, to which Abernathy replied:

“The only thing that we can say,…